renal-cell-carcinoma

Documents about renal-cell-carcinoma

• Hallmarks of adaptive immunity in a metastatic clear cell renal cell carcinoma (ccRCC) long-term elite survivor#307825Europe PMC
• Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule#851778ClinicalTrials.gov
• Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC#903840ClinicalTrials.gov
• Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma#1045631ClinicalTrials.gov
• A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors#835885ClinicalTrials.gov
• A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers#67870ClinicalTrials.gov
• High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2#810391ClinicalTrials.gov
• Hybrid DenseNet-U-Net framework for automated grading of renal cell carcinoma.#196090NCBI PubMed Central
• Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)#230424ClinicalTrials.gov
• CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition#234413ClinicalTrials.gov
• Protocol for constructing an orthotopic mouse model of metastatic renal cell carcinoma.#320520NCBI PubMed Central
• LCAT exhibits subtype specific prognostic and immunometabolic associations in renal cell carcinoma.#610326NCBI PubMed Central
• RCC-AID: Renal Cell Carcinoma AI Dataset for Medical Imaging Research#640126bioRxiv / medRxiv
• Therapeutic challenges of a renal collision tumour comprising clear cell renal cell carcinoma and metastatic breast carcinoma: a case report.#486261Apollo
• Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase Inhibitors#839476ClinicalTrials.gov
• Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial#14272HAL (France)
• NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts#180366ClinicalTrials.gov
• [Hierarchical attention-driven multiple instance learning for clear cell renal cell carcinoma grading and staging in digital pathology].#236056NCBI PubMed Central
• Establishment of a clear cell renal cell carcinoma organoid cohort integrated into the UroCCR clinical database: A feasibility study#677149HAL (France)
• Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients#904464ClinicalTrials.gov
• Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250#848878ClinicalTrials.gov
• Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)#343845ClinicalTrials.gov
• A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab#905524ClinicalTrials.gov
• Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy#136304ClinicalTrials.gov
• Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms#825469ClinicalTrials.gov
• Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC#840765ClinicalTrials.gov
• A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma#1046131ClinicalTrials.gov
• Safety Study of MGD009 in B7-H3-expressing Tumors#894828ClinicalTrials.gov
• Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors#882884ClinicalTrials.gov
• Comprehensive analysis of ATF3 as a diagnostic and prognostic biomarker from pan-cancer to clear cell renal cell carcinoma.#148206NCBI PubMed Central
• Integrative multi-omics identifies PANX2 as a ferroptosis suppressor and potential therapeutic target in clear cell renal cell carcinoma.#465138NCBI PubMed Central
• Performance of Machine Learning Models Based on Medical Imaging in Predicting Pathological Grade of Clear Cell Renal Cell Carcinoma.#659579NCBI PubMed Central
• Mechanism of Action Trial of ColoAd1#807673ClinicalTrials.gov
• Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies#849452ClinicalTrials.gov
• Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors#18589ClinicalTrials.gov
• Pituitary gland metastasis from renal cell carcinoma presented as a non-functioning macroadenoma#342315Lume 5.8
• A Phase 1 Study of the Safety and Tolerability of CTX-10726#846001ClinicalTrials.gov
• Quantifying Systemic Immunosuppression to Personalize Cancer Therapy#851374ClinicalTrials.gov
• A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)#842721ClinicalTrials.gov
• Differentiation of Small Clear Renal Cell Carcinoma and Oncocytoma through Magnetic Resonance Imaging-Based Radiomics Analysis: Toward the End of Percutaneous Biopsy#205852HAL (France)
• Development and validation of an integrated machine learning model for recurrence-free survival prediction in clear cell renal cell carcinoma.#439328NCBI PubMed Central
• Dietary Polyphenol Acteoside-Related Molecular Signatures in Clear Cell Renal Cell Carcinoma: Multi-Omics Profiling and Functional Validation of IMPDH1.#653388NCBI PubMed Central
• Single-Cell and Machine Learning Analyses Identify MYDGF as an Immune-Related Biomarker Associated With the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.#404343NCBI PubMed Central
• Synergistic Sono-Chemodynamic Therapy of Renal Cell Carcinoma Using HKUST-1@TiO(2) Heterojunctions.#138438NCBI PubMed Central
• Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing.#154438NCBI PubMed Central
• Tobacco Exposure and Risk of Renal Cell Carcinoma: A Case-control Study#182030Europe PMC
• Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer#424171ClinicalTrials.gov
• Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients#831251ClinicalTrials.gov
• Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)#874785ClinicalTrials.gov
• Evaluation of a Laparoscopic High Intensity Focused Ultrasound Probe for the Ablation of Small Renal Masses#867714ClinicalTrials.gov